LVivo IQS

by DiA Imaging Analysis  · Based in Israel → — AI-powered ultrasound analysis solutions for smarter, faster, and more accessible image interpretation.
Cardiology Emergency Medicine Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

LVivo IQS (Image Quality Score) by DiA Imaging Analysis (a Philips company) is a vendor-neutral, AI-powered software application designed to assist clinicians during cardiac ultrasound examinations. The tool provides real-time feedback on image quality during the acquisition process to help users capture optimal, interpretable cardiac images.

The software is primarily intended for healthcare professionals performing echocardiography across various clinical environments, including point-of-care ultrasound (POCUS) settings, emergency departments, intensive care units, and traditional echo labs. It is designed to support both experienced sonographers and clinicians with varying levels of scanning experience.

LVivo IQS integrates directly into the clinical scanning workflow. As the user performs an ultrasound, the AI scans the left ventricle and evaluates the image in real time. It generates immediate feedback using a color-coded system and numerical scoring to indicate the quality of the active scan. This guidance helps the operator adjust the transducer position to secure high-quality, clinically useful images suitable for subsequent diagnostic analysis.

  • Real-time feedback: Delivers instantaneous quality scoring during active scanning.
  • Visual guidance: Uses intuitive numerical scores and color indicators to guide transducer placement.
  • Vendor-neutral integration: Designed to operate compatibly across various ultrasound hardware platforms.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered real-time image quality feedback (LVivo IQS)
  • Automated analysis of ultrasound images
  • Vendor-neutral software solution
  • Global and segmental left ventricle (LV) function evaluation (ejection fraction, strain, wall motion)
  • Right ventricular (RV) function evaluation
  • Bladder volume measurement (as part of the broader LVivo platform)
  • Reduces variability and increases efficiency in image interpretation
  • Supports clinical decision-making
  • Trained on a large database of ultrasound images in collaboration with leading medical centers

Use Cases

  • Real-time assessment of cardiac ultrasound image quality during acquisition
  • Automated analysis of echocardiographic examinations
  • Evaluating left and right ventricular function
  • Detecting clinical abnormalities in heart function
  • Improving efficiency and accuracy in ultrasound diagnostics
  • Supporting point-of-care ultrasound settings

What Physicians Need to Know

Echocardiography AI Features
LVivo IQS provides real-time feedback on echocardiography image quality, scanning the left ventricle and tracking overall cardiac performance. It rates image quality using numerical scoring and colors to guide users in acquiring high-quality, interpretable cardiac ultrasound images. Other solutions within the LVivo suite offer automated measurements for ejection fraction, global longitudinal strain, right ventricle size and function, and segmental wall motion from echocardiography studies.
Real-Time Alert Capability
The software offers real-time feedback on image quality during the echocardiography exam, using colors and numerical scores to assist users in capturing optimal images.
Cardiac Monitoring Integration
LVivo IQS is a vendor-neutral software solution designed to integrate with existing IT/PACS systems and various ultrasound devices.
AHA/ACC Guideline Alignment
DiA Imaging Analysis, the developer of LVivo IQS, has exhibited its AI software suite at the American College of Cardiology (ACC) Annual Scientific Session & Expo.
Physician Tip

Leverage LVivo IQS's real-time image quality feedback to optimize echocardiography acquisition, especially for less experienced users, thereby reducing variability and improving diagnostic confidence. The ability to obtain high-quality, interpretable images faster can aid in more accurate and timely clinical decision-making for cardiac health problems.

LVivo IQS is designed as a vendor-neutral AI-powered software solution, enabling integration with a wide range of existing ultrasound devices and healthcare IT/PACS systems for seamless workflow incorporation.

Details

Category Cardiology AI
Pricing Contact for pricing
DeploymentOn ultrasound devices (near bedside) and off-line on healthcare IT PACS systems/servers.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

LVivo IQS is part of the DiA LVivo Software Application, which received FDA 510(k) clearance (K243862) on March 17, 2025. LVivo IQS specifically received 510(k) clearance on February 6, 2023, for providing real-time image quality feedback during cardiac ultrasound scanning.

Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Radiology

What the Web Says

LVivo IQS is a software solution from DIA Analysis designed to automate the analysis of echocardiography images, aiming to improve efficiency and reduce variability in cardiac assessments. Reviews suggest it is particularly valued for its AI-driven automation and integration capabilities within existing healthcare workflows.

Overall: Positive

Strengths

  • Automated analysis of echocardiograms saves time for cardiologists.
  • Reduces inter-observer variability in measurements, leading to more consistent results.
  • AI-powered algorithms provide objective and quantitative data.
  • Seamless integration with PACS and EMR systems reported.
  • User-friendly interface, making it easy for clinicians to adopt.
  • Potential to improve diagnostic accuracy and patient management.

Limitations

  • Initial setup and integration might require IT support.
  • Reliance on AI may raise concerns about 'black box' decision-making for some clinicians.
  • Cost of implementation and ongoing licensing fees could be a barrier for smaller practices.
  • Requires high-quality input images for optimal performance.
  • Limited information available on specific physician forums or widespread tech review sites like G2/Capterra.
  • Some users might prefer manual control over fully automated processes for certain complex cases.

Based on reviews from: DIA Analysis official website, Healthcare IT news articles, Medical technology review sites (general), Clinical studies and white papers, Industry publications

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate LVivo IQS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
DiA Secures FDA Clearance for New AI-Powered Software, Assisting Ultrasound Users To Capture High-Quality Images
DiA Imaging Analysis announced FDA clearance for LVivo IQS, an AI-based software that provides real-time image quality feedback during cardiac ultrasound exams to help users acquire high-quality, interpretable images. This is DiA's first FDA-approved software solution to offer real-time feedback for image capture.
2023-02
Diagnostic Imaging
Adjunctive AI Software for Cardiac Ultrasound Gets FDA Nod
The FDA granted 510(k) clearance to LVivo IQS from DiA Imaging Analysis, an AI-enabled quality scoring system for cardiac ultrasound images that provides real-time feedback with colors and numerical scores. A clinical study showed that 91% of point-of-care cardiac ultrasound images obtained by residents using LVivo IQS were deemed clinically interpretable by cardiologists.
2023-02
ITN Online
DiA Received FDA Clearance for New AI Software, Helping Ultrasound Users Capture High-Quality Images
DiA Imaging Analysis received FDA clearance for LVivo IQS, an AI-based vendor-neutral software solution designed to help ultrasound users acquire high-quality interpretable cardiac ultrasound images. The software provides real-time image quality feedback while scanning the left ventricle of the heart.
2023-02
Globes
US FDA approves DiA's new AI-powered ultrasound software LVivo ...
DiA Imaging Analysis, an Israeli AI-based ultrasound software provider, secured US Food and Drug Administration approval for LVivo IQS.
2023-02
Fierce Biotech
FDA hands DiA Imaging another AI clearance in cardiac ultrasound
The FDA has cleared DiA Imaging Analysis's LVivo IQS, an AI program that provides real-time feedback to clinicians during cardiac ultrasound exams to help capture clear and accurate scans. This marks DiA's ninth FDA clearance, and its first to offer real-time feedback during image acquisition.
2023-02
sepStreamu00ae News & Information
AI-powered Cardiac Imaging Solution Gets FDA Approval
The FDA has approved LVivo IQS, an AI-powered, vendor-neutral solution from sepStreamu00ae (DiA Imaging Analysis), which will enable medical practitioners to obtain high-quality echocardiography images and make faster, more accurate diagnoses of cardiac health problems. The software provides real-time feedback on image quality using numerical scoring and colors.
2023-03
DOTmed
Philips buys DiA Imaging Analysis for almost $100 million: report
Philips is reportedly acquiring DiA Imaging Analysis, the Israeli developer of AI-powered technology for heart ultrasound imaging analysis, for slightly under $100 million. This acquisition follows DiA's FDA clearance for LVivo IQS in February, which is one of DiA's nine FDA-approved software solutions.
2023-05
PMC (PubMed Central)
Machine Learning-Enabled Medical Devices Authorized by the US Food and Drug Administration in 2024: Regulatory Characteristics, Predicate Lineage, and Transparency Reporting
LVivo IQS (K240769) is listed as a machine learning-enabled medical device authorized by the FDA in 2024 via the 510(k) pathway for left ventricular function analysis. This article provides a comprehensive assessment of AI/ML-enabled medical devices cleared or approved by the FDA in 2024.
2025-12

Videos

Product demos, reviews, and walkthroughs for LVivo IQS.

View all on YouTube

No FAQs available yet for this tool.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from DiA Imaging Analysis

LVivo Seamless
DiA Imaging Analysis
Cardiology AI
LVivo Seamless by DiA Imaging Analysis is an AI-based software solution that automates the analysis of cardiac ultrasound images, providing fast, accurate, and objective measurements of heart function directly within the existing workflow.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18

Investors who backed LVivo IQS

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.